Literature DB >> 15809840

[Ultrasound contrast agents: substance classes, pharmacokinetics, clinical applications, safety aspects].

C Krestan1.   

Abstract

Ultrasound contrast agents (UCA) have undergone constant development and improvement in recent years. Greater mechanical stability and improved acoustic properties, combined with new contrast-specific ultrasound sequences, have broadened the potential fields for investigation considerably. Contrast-enhanced ultrasound studies will no longer be complementary investigations, but will be considered as primary techniques. This review article provides a survey of the different drugs used, their chemical properties, and their pharmacokinetic aspects. Summarized are the most important established and published indications for the use of UCA together with an outlook for future applications. Finally this paper discusses the safety profile of these agents, which has become important due to the increasing use of these agents.

Mesh:

Substances:

Year:  2005        PMID: 15809840     DOI: 10.1007/s00117-005-1191-4

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  57 in total

1.  [3D real time contrast enhanced ultrasonography,a new technique].

Authors:  C F Dietrich
Journal:  Rofo       Date:  2002-02

2.  [Contrast-medium enhanced reflux ultrasound in children. A comparison with radiologic imaging up to now].

Authors:  C Radmayr; J Oswald; A Klauser; G Bartsch; F Frauscher
Journal:  Urologe A       Date:  2002-11       Impact factor: 0.639

3.  [Diagnostic imaging in polytrauma: comparison of radiation exposure from whole-body MSCT and conventional radiography with organ-specific CT].

Authors:  U Wedegärtner; M Lorenzen; H D Nagel; C Weber; G Adam
Journal:  Rofo       Date:  2004-07

4.  The use of contrast-enhanced ultrasound in large vessels.

Authors:  A Martegani; L Aiani; C Borghi
Journal:  Eur Radiol       Date:  2004-10       Impact factor: 5.315

5.  The advances are significant improvements in both the microbubbles used as contrast agents and in the software that allows their selective detection.

Authors:  David Cosgrove
Journal:  Eur Radiol       Date:  2004-10       Impact factor: 5.315

6.  Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US--early experience.

Authors:  S Huber; T Helbich; J Kettenbach; W Dock; I Zuna; S Delorme
Journal:  Radiology       Date:  1998-08       Impact factor: 11.105

7.  Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: preliminary experience.

Authors:  T Albrecht; A Urbank; M Mahler; A Bauer; C J Doré; M J Blomley; D O Cosgrove; R Schlief
Journal:  Radiology       Date:  1998-05       Impact factor: 11.105

8.  Abdominal aortic aneurysm: contrast-enhanced US for missed endoleaks after endoluminal repair.

Authors:  Vinicio Napoli; Irene Bargellini; Savino G Sardella; Pasquale Petruzzi; Roberto Cioni; Claudio Vignali; Mauro Ferrari; Carlo Bartolozzi
Journal:  Radiology       Date:  2004-10       Impact factor: 11.105

9.  Contrast-enhanced power Doppler sonography in breast lesions: effect on differential diagnosis after mammography and gray scale sonography.

Authors:  Ayşegül Zdemir; Koray Kiliç; Hakan Ozdemir; Cem Yücel; Sebnem Andaç; Meriç Colak
Journal:  J Ultrasound Med       Date:  2004-02       Impact factor: 2.153

10.  Renal perfusion abnormality. Coded harmonic angio US with contrast agent.

Authors:  J H Kim; H W Eun; H K Lee; S J Park; J H Shin; J H Hwang; D E Goo; D L Choi
Journal:  Acta Radiol       Date:  2003-03       Impact factor: 1.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.